167 related articles for article (PubMed ID: 35581637)
1. Radiogenomic analysis of primary breast cancer reveals [18F]-fluorodeoxglucose dynamic flux-constants are positively associated with immune pathways and outperform static uptake measures in associating with glucose metabolism.
Ralli GP; Carter RD; McGowan DR; Cheng WC; Liu D; Teoh EJ; Patel N; Gleeson F; Harris AL; Lord SR; Buffa FM; Fenwick JD
Breast Cancer Res; 2022 May; 24(1):34. PubMed ID: 35581637
[TBL] [Abstract][Full Text] [Related]
2. PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.
Dunnwald LK; Doot RK; Specht JM; Gralow JR; Ellis GK; Livingston RB; Linden HM; Gadi VK; Kurland BF; Schubert EK; Muzi M; Mankoff DA
Clin Cancer Res; 2011 Apr; 17(8):2400-9. PubMed ID: 21364034
[TBL] [Abstract][Full Text] [Related]
3. First results on kinetic modelling and parametric imaging of dynamic
Sari H; Mingels C; Alberts I; Hu J; Buesser D; Shah V; Schepers R; Caluori P; Panin V; Conti M; Afshar-Oromieh A; Shi K; Eriksson L; Rominger A; Cumming P
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1997-2009. PubMed ID: 34981164
[TBL] [Abstract][Full Text] [Related]
4. Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.
Røe K; Aleksandersen TB; Kristian A; Nilsen LB; Seierstad T; Qu H; Ree AH; Olsen DR; Malinen E
Acta Oncol; 2010 Oct; 49(7):914-21. PubMed ID: 20831478
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.
Vriens D; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e725-31. PubMed ID: 22330998
[TBL] [Abstract][Full Text] [Related]
7. Abbreviated scan protocols to capture
Viswanath V; Sari H; Pantel AR; Conti M; Daube-Witherspoon ME; Mingels C; Alberts I; Eriksson L; Shi K; Rominger A; Karp JS
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3215-3225. PubMed ID: 35278108
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
Tixier F; Vriens D; Cheze-Le Rest C; Hatt M; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP; Visvikis D
J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by
van Berkel A; Vriens D; Visser EP; Janssen MJR; Gotthardt M; Hermus ARMM; Geus-Oei LF; Timmers HJLM
J Nucl Med; 2019 Jun; 60(6):745-751. PubMed ID: 30413658
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
Kurland BF; Muzi M; Peterson LM; Doot RK; Wangerin KA; Mankoff DA; Linden HM; Kinahan PE
J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors.
Cochet A; Pigeonnat S; Khoury B; Vrigneaud JM; Touzery C; Berriolo-Riedinger A; Dygai-Cochet I; Toubeau M; Humbert O; Coudert B; Fumoleau P; Arnould L; Brunotte F
J Nucl Med; 2012 Apr; 53(4):512-20. PubMed ID: 22343501
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
13. Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.
Krak NC; van der Hoeven JJ; Hoekstra OS; Twisk JW; van der Wall E; Lammertsma AA
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):674-81. PubMed ID: 12640556
[TBL] [Abstract][Full Text] [Related]
14. The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake.
Wolf G; Aigner RM; Schaffler G; Langsenlehner U; Renner W; Samonigg H; Yazdani-Biuki B; Krippl P
Breast Cancer Res Treat; 2004 Dec; 88(3):205-8. PubMed ID: 15609122
[TBL] [Abstract][Full Text] [Related]
15. Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach.
Sundaram SK; Freedman NM; Carrasquillo JA; Carson JM; Whatley M; Libutti SK; Sellers D; Bacharach SL
J Nucl Med; 2004 Aug; 45(8):1328-33. PubMed ID: 15299057
[TBL] [Abstract][Full Text] [Related]
16. Positron Emission Tomography (PET) and Pharmacokinetics: Classical Blood Sampling Versus Image-Derived Analysis of [18F]FAZA and [18F]FDG in a Murine Tumor Bearing Model.
Jans HS; Yang XH; Brocks DR; Kumar P; Wuest M; Wiebe LI
J Pharm Pharm Sci; 2018; 21(1s):32s-47s. PubMed ID: 29702045
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy.
Tseng J; Dunnwald LK; Schubert EK; Link JM; Minoshima S; Muzi M; Mankoff DA
J Nucl Med; 2004 Nov; 45(11):1829-37. PubMed ID: 15534051
[TBL] [Abstract][Full Text] [Related]
18. Dynamic 2-Deoxy-2-[
Kristian A; Holtedahl JE; Torheim T; Futsaether C; Hernes E; Engebraaten O; Mælandsmo GM; Malinen E
Mol Imaging Biol; 2017 Apr; 19(2):271-279. PubMed ID: 27541026
[TBL] [Abstract][Full Text] [Related]
19. Combined hyperpolarized
Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
[TBL] [Abstract][Full Text] [Related]
20. Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.
Partridge SC; Vanantwerp RK; Doot RK; Chai X; Kurland BF; Eby PR; Specht JM; Dunnwald LK; Schubert EK; Lehman CD; Mankoff DA
J Magn Reson Imaging; 2010 Nov; 32(5):1124-31. PubMed ID: 21031518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
